![](/img/cover-not-exists.png)
Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation
Nicolini, F. E., Hayette, S., Corm, S., Bachy, E., Bories, D., Tulliez, M., Guilhot, F., Legros, L., Maloisel, F., Kiladjian, J.-J., Mahon, F.-X., Le, Q.-H., Michallet, M., Roche-Lestienne, C., PreudhVolume:
92
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.11369
Date:
September, 2007
File:
PDF, 190 KB
english, 2007